Degnan Chris sold URGN
October 8, 2026 · Form 4 insider transaction
Degnan Chris sold 2,202 shares of UroGen Pharma Ltd. at $36.69 per share, a transaction worth $80.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,202
Price
$36.69
Total value
$80.8K
InsiderDegnan Chris
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateOctober 8, 2026
Filing dateOctober 9, 2026
Shares owned after4,561
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.